Newborn Health And Mobility Programs
To improve the health of poor patients served by resource-limited medical facilities.
Medical devices on the market are too expensive for resource limited medical facilities.
D-Rev designs, develops, licenses and distributes affordable medical devices that meet the needs of low-resource health facilities, including a phototherapy device for neonatal jaundice and a prosthetic knee.
Number of devices effectively in use
Deaths and disabilities averted (reported in DALYs)
Impact and Cost
Approximately $600 per DALY avertedImpact and Cost Calculation
The impact of Brilliance is calculated using the number of patients treated over the device lifetime, the rate of reduction in kernicterus cases and the disability-adjusted life year (DALY) value of averting a case. The impact of ReMotion is the DALY reduction from untreated to treated limb amputations for the one month of ReMotion sales during 2013-15 period. In the average year from 2013-15, it cost $22 million to avert 38,000 DALYs. Of that cost, D-Rev paid $1 million and patients and hospitals paid $21 million.
Quality of Evidence
Quality of Evidence Assessment
D-Rev produces a phototherapy device (Brilliance) for neonatal jaundice and a prosthetic knee (ReMotion Knee). There is strong clinical evidence that phototherapy improves outcomes. However, D-Rev has weak internal evidence on whether Brilliance is administered correctly, who it is administered to and whether they would otherwise receive treatment. Strong clinical evidence shows that prostheses such as D-Rev’s ReMotion Knee improve outcomes. However, similarly to Brilliance, D-Rev has only low-quality internal evidence on its impact.
Quality of Monitoring Systems
D-Rev’s monitoring systems are adequate and often very good. However, several of D-Rev’s systems have limitations that reduce accuracy. Most importantly, D-Rev only collects data from hospitals that are easy to reach and relies on assumptions about device use that may be out of date. As D-Rev delivers its devices through the market, data collection is challenging and costly.
Learning and Iteration
D-Rev has an exceptional research and development process. Over the last three years, D-Rev has considered four changes to the design of its program and adopted three. Decisions to implement changes were supported by high-quality data and were arrived at systematically. Furthermore, D-Rev regularly researches and reviews new changes.
|Iteration is based on data||Yes|
|Data are of high quality||Yes|
|Iteration is systematic and periodic||Yes|